| Year |
Citation |
Score |
| 2023 |
Ware OD, Sweeney MM, Cunningham C, Umbricht A, Stitzer M, Dunn KE. Bupropion Slow Release vs Placebo With Adaptive Incentives for Cocaine Use Disorder in Persons Receiving Methadone for Opioid Use Disorder: A Randomized Clinical Trial. Jama Network Open. 6: e232278. PMID 36920397 DOI: 10.1001/jamanetworkopen.2023.2278 |
0.737 |
|
| 2018 |
Schlienz NJ, Lee DC, Stitzer ML, Vandrey R. The effect of high-dose dronabinol (oral THC) maintenance on cannabis self-administration. Drug and Alcohol Dependence. 187: 254-260. PMID 29689485 DOI: 10.1016/J.Drugalcdep.2018.02.022 |
0.806 |
|
| 2018 |
Martin EL, Schlienz NJ, Herrmann ES, Budney AJ, Lee DC, Hampson A, Smith M, Leoutsakos JS, Stitzer ML, Vandrey RG. 1000 Targeting Sleep in Adults Seeking Treatment for Cannabis Use Disorder Sleep. 41: A370-A370. DOI: 10.1093/Sleep/Zsy061.999 |
0.764 |
|
| 2018 |
Vandrey R, Budney A, Herrmann E, Schlienz N, Hampson A, Smith M, Stitzer M. 166. Targeting Sleep Disturbance in the Treatment of Cannabis Use Disorders Biological Psychiatry. 83: S67. DOI: 10.1016/J.Biopsych.2018.02.184 |
0.762 |
|
| 2017 |
Stitzer M, Matheson T, Cunningham C, Sorensen JL, Feaster DJ, Gooden L, Hammond AS, Fitzsimons H, Metsch LR. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addiction Science & Clinical Practice. 12: 16. PMID 28651612 DOI: 10.1186/S13722-017-0081-1 |
0.709 |
|
| 2017 |
Stitzer ML, Schwartz RP, Bigelow GE. Prescription opioids: New perspectives and research on their role in chronic pain management and addiction. Drug and Alcohol Dependence. 173: S1-S3. PMID 28363314 DOI: 10.1016/j.drugalcdep.2016.11.018 |
0.433 |
|
| 2016 |
Lévesque A, Campbell AN, Pavlicova M, Hu MC, Walker R, McClure EA, Ghitza UE, Bailey G, Stitzer M, Nunes EV. Coping strategies as a mediator of internet-delivered psychosocial treatment: Secondary analysis from a NIDA CTN multisite effectiveness trial. Addictive Behaviors. 65: 74-80. PMID 27776269 DOI: 10.1016/J.Addbeh.2016.09.012 |
0.717 |
|
| 2016 |
Higgins ST, Heil SH, Sigmon SC, Tidey JW, Gaalema DE, Stitzer ML, Durand H, Bunn JY, Priest JS, Arger CA, Miller ME, Bergeria CL, Davis DR, Streck JM, Zvorsky I, et al. Response to varying the nicotine content of cigarettes in vulnerable populations: an initial experimental examination of acute effects. Psychopharmacology. PMID 27714427 DOI: 10.1007/S00213-016-4438-Z |
0.756 |
|
| 2016 |
Stitzer M, Calsyn D, Matheson T, Sorensen J, Gooden L, Metsch L. Development of a Multi-Target Contingency Management Intervention for HIV Positive Substance Users. Journal of Substance Abuse Treatment. PMID 27624618 DOI: 10.1016/J.Jsat.2016.08.018 |
0.339 |
|
| 2015 |
Cunningham C, Stitzer M, Campbell AN, Pavlicova M, Hu MC, Nunes EV. Contingency management abstinence incentives: Cost and implications for treatment tailoring. Journal of Substance Abuse Treatment. PMID 26482136 DOI: 10.1016/J.Jsat.2015.08.010 |
0.713 |
|
| 2015 |
Donny EC, Denlinger RL, Tidey JW, Koopmeiners JS, Benowitz NL, Vandrey RG, al'Absi M, Carmella SG, Cinciripini PM, Dermody SS, Drobes DJ, Hecht SS, Jensen J, Lane T, Le CT, ... ... Stitzer ML, et al. Randomized Trial of Reduced-Nicotine Standards for Cigarettes. The New England Journal of Medicine. 373: 1340-1349. PMID 26422724 DOI: 10.1056/Nejmsa1502403 |
0.772 |
|
| 2015 |
Lai H, Stitzer M, Treisman G, Moore R, Brinker J, Gerstenblith G, Kickler TS, Li J, Chen S, Fishman E, Lai S. Cocaine Abstinence and Reduced Use Associated With Lowered Marker of Endothelial Dysfunction in African Americans: A Preliminary Study. Journal of Addiction Medicine. 9: 331-9. PMID 26164164 DOI: 10.1097/Adm.0000000000000140 |
0.319 |
|
| 2015 |
Cochran G, Stitzer M, Campbell AN, Hu MC, Vandrey R, Nunes EV. Web-based treatment for substance use disorders: differential effects by primary substance. Addictive Behaviors. 45: 191-4. PMID 25697725 DOI: 10.1016/j.addbeh.2015.02.002 |
0.709 |
|
| 2015 |
Mitchell SG, Schwartz RP, Alvanzo AA, Weisman MS, Kyle TL, Turrigiano EM, Gibson ML, Perez L, McClure EA, Clingerman S, Froias A, Shandera DR, Walker R, Babcock DL, Bailey GL, ... ... Stitzer ML, et al. The Use of Technology in Participant Tracking and Study Retention: Lessons Learned from a Clinical Trials Network Study. Substance Abuse : Official Publication of the Association For Medical Education and Research in Substance Abuse. 0. PMID 25671593 DOI: 10.1080/08897077.2014.992565 |
0.699 |
|
| 2015 |
McClure EA, Campbell AN, Pavlicova M, Hu M, Winhusen T, Vandrey RG, Ruglass LM, Covey LS, Stitzer ML, Kyle TL, Nunes EV. Cigarette Smoking During Substance Use Disorder Treatment: Secondary Outcomes from a National Drug Abuse Treatment Clinical Trials Network study. Journal of Substance Abuse Treatment. 53: 39-46. PMID 25595301 DOI: 10.1016/J.Jsat.2014.12.007 |
0.807 |
|
| 2015 |
Keyser-Marcus L, Alvanzo A, Rieckmann T, Thacker L, Sepulveda A, Forcehimes A, Islam LZ, Leisey M, Stitzer M, Svikis DS. Trauma, gender, and mental health symptoms in individuals with substance use disorders. Journal of Interpersonal Violence. 30: 3-24. PMID 24811286 DOI: 10.1177/0886260514532523 |
0.313 |
|
| 2015 |
Frimpong JA, Metsch LR, Duan R, Feaster DF, Shiu K, Matheson T, DeMicco E, Sorensen J, Walker R, Drainoni M, Gaskin S, Stitzer M, Mandler R, Farber E, del Rio C. Substance use disorders treatment history among hospitalized HIV-infected substance users in 11 U.S. cities Drug and Alcohol Dependence. 156: e75. DOI: 10.1016/J.Drugalcdep.2015.07.1121 |
0.341 |
|
| 2015 |
Vandrey R, Budney AJ, Smith M, Herrmann E, Hampson A, Stitzer M. A pilot study of zolpidem pharmacotherapy in the treatment of cannabis use disorders Drug and Alcohol Dependence. 146: e10. DOI: 10.1016/J.Drugalcdep.2014.09.708 |
0.749 |
|
| 2014 |
Aklin WM, Wong CJ, Hampton J, Svikis DS, Stitzer ML, Bigelow GE, Silverman K. A therapeutic workplace for the long-term treatment of drug addiction and unemployment: eight-year outcomes of a social business intervention. Journal of Substance Abuse Treatment. 47: 329-38. PMID 25124257 DOI: 10.1016/J.Jsat.2014.06.013 |
0.645 |
|
| 2014 |
Acquavita SP, McClure EA, Hargraves D, Stitzer M. Environmental tobacco smoke exposure among smokers and non-smokers receiving outpatient substance abuse treatment. Addictive Behaviors. 39: 1718-22. PMID 25117848 DOI: 10.1016/J.Addbeh.2014.07.016 |
0.72 |
|
| 2014 |
Campbell AN, Nunes EV, Matthews AG, Stitzer M, Miele GM, Polsky D, Turrigiano E, Walters S, McClure EA, Kyle TL, Wahle A, Van Veldhuisen P, Goldman B, Babcock D, Stabile PQ, et al. Internet-delivered treatment for substance abuse: a multisite randomized controlled trial. The American Journal of Psychiatry. 171: 683-90. PMID 24700332 DOI: 10.1176/Appi.Ajp.2014.13081055 |
0.744 |
|
| 2014 |
Rass O, Kleykamp BA, Vandrey RG, Bigelow GE, Leoutsakos JM, Stitzer ML, Strain EC, Copersino ML, Mintzer MZ. Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose level. Experimental and Clinical Psychopharmacology. 22: 248-56. PMID 24548244 DOI: 10.1037/A0035712 |
0.783 |
|
| 2014 |
McClure EA, Acquavita SP, Dunn KE, Stoller KB, Stitzer ML. Characterizing smoking, cessation services, and quit interest across outpatient substance abuse treatment modalities. Journal of Substance Abuse Treatment. 46: 194-201. PMID 23988192 DOI: 10.1016/J.Jsat.2013.07.009 |
0.735 |
|
| 2014 |
Vandrey R, Stitzer M. Effect of dronabinol (oral THC) maintenance on cannabis self-administration Drug and Alcohol Dependence. 140: e232. DOI: 10.1016/J.Drugalcdep.2014.02.643 |
0.667 |
|
| 2014 |
Khalil M, Stitzer M, Vandrey R. Sleep quality among cannabis users seeking treatment Drug and Alcohol Dependence. 140: e102-e103. DOI: 10.1016/J.Drugalcdep.2014.02.296 |
0.653 |
|
| 2014 |
Cochran G, Stitzer M, Nunes EV, Hu M, Campbell A. Early treatment drug use: Drug-positive vs. -negative patients Drug and Alcohol Dependence. 140. DOI: 10.1016/J.Drugalcdep.2014.02.119 |
0.339 |
|
| 2013 |
Sheffer C, Stitzer M, Landes R, Brackman SL, Munn T. In-person and telephone treatment of tobacco dependence: a comparison of treatment outcomes and participant characteristics. American Journal of Public Health. 103: e74-82. PMID 23763416 DOI: 10.2105/Ajph.2012.301144 |
0.374 |
|
| 2013 |
DeFulio A, Stitzer M, Roll J, Petry N, Nuzzo P, Schwartz RP, Stabile P. Criminal justice referral and incentives in outpatient substance abuse treatment. Journal of Substance Abuse Treatment. 45: 70-5. PMID 23433822 DOI: 10.1016/J.Jsat.2012.12.012 |
0.398 |
|
| 2013 |
Acquavita SP, Stershic S, Sharma R, Stitzer M. Client incentives versus contracting and staff incentives: how care continuity interventions in substance abuse treatment can improve residential to outpatient transition. Journal of Substance Abuse Treatment. 45: 55-62. PMID 23375361 DOI: 10.1016/J.Jsat.2012.12.010 |
0.35 |
|
| 2013 |
McClure EA, Acquavita SP, Harding E, Stitzer ML. Utilization of communication technology by patients enrolled in substance abuse treatment. Drug and Alcohol Dependence. 129: 145-50. PMID 23107600 DOI: 10.1016/J.Drugalcdep.2012.10.003 |
0.712 |
|
| 2013 |
Vandrey R, Stitzer ML, Mintzer MZ, Huestis MA, Murray JA, Lee D. The dose effects of short-term dronabinol (oral THC) maintenance in daily cannabis users. Drug and Alcohol Dependence. 128: 64-70. PMID 22921474 DOI: 10.1016/J.Drugalcdep.2012.08.001 |
0.804 |
|
| 2013 |
McClure EA, Vandrey RG, Johnson MW, Stitzer ML. Effects of varenicline on abstinence and smoking reward following a programmed lapse. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 139-48. PMID 22573730 DOI: 10.1093/Ntr/Nts101 |
0.789 |
|
| 2012 |
Winhusen T, Brady KT, Stitzer M, Woody G, Lindblad R, Kropp F, Brigham G, Liu D, Sparenborg S, Sharma G, Vanveldhuisen P, Adinoff B, Somoza E. Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world. Contemporary Clinical Trials. 33: 993-1002. PMID 22613054 DOI: 10.1016/J.Cct.2012.05.003 |
0.442 |
|
| 2012 |
Sheffer CE, Stitzer M, Landes R, Brackman SL, Munn T, Moore P. Socioeconomic disparities in community-based treatment of tobacco dependence. American Journal of Public Health. 102: e8-16. PMID 22390525 DOI: 10.2105/Ajph.2011.300519 |
0.395 |
|
| 2012 |
Tuten M, DeFulio A, Jones HE, Stitzer M. Abstinence-contingent recovery housing and reinforcement-based treatment following opioid detoxification. Addiction (Abingdon, England). 107: 973-82. PMID 22151478 DOI: 10.1111/J.1360-0443.2011.03750.X |
0.45 |
|
| 2012 |
Campbell AN, Nunes EV, Miele GM, Matthews A, Polsky D, Ghitza UE, Turrigiano E, Bailey GL, VanVeldhuisen P, Chapdelaine R, Froias A, Stitzer ML, Carroll KM, Winhusen T, Clingerman S, et al. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: an example from the NIDA Clinical Trials Network. Contemporary Clinical Trials. 33: 386-95. PMID 22085803 DOI: 10.1016/J.Cct.2011.11.001 |
0.736 |
|
| 2012 |
Winhusen T, Stitzer M, Woody G, Brigham G, Kropp F, Ghitza U, Lindblad R, Adinoff B, Green C, Sharma G, Somoza E. Design considerations for a study to evaluate the impact of smoking cessation treatment on stimulant use outcomes in stimulant-dependent individuals. Contemporary Clinical Trials. 33: 197-205. PMID 22005174 DOI: 10.1016/J.Cct.2011.09.018 |
0.326 |
|
| 2012 |
McClure EA, Stitzer ML, Vandrey R. Characterizing smoking topography of cannabis in heavy users. Psychopharmacology. 220: 309-18. PMID 21922170 DOI: 10.1007/S00213-011-2480-4 |
0.795 |
|
| 2011 |
Hser YI, Li J, Jiang H, Zhang R, Du J, Zhang C, Zhang B, Evans E, Wu F, Chang YJ, Peng C, Huang D, Stitzer ML, Roll J, Zhao M. Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction (Abingdon, England). 106: 1801-9. PMID 21793958 DOI: 10.1111/J.1360-0443.2011.03490.X |
0.322 |
|
| 2011 |
Vandrey R, Stitzer ML, Acquavita SP, Quinn-Stabile P. Pay-for-performance in a community substance abuse clinic. Journal of Substance Abuse Treatment. 41: 193-200. PMID 21489739 DOI: 10.1016/J.Jsat.2011.03.001 |
0.706 |
|
| 2010 |
Stitzer ML, Petry NM, Peirce J. Motivational incentives research in the National Drug Abuse Treatment Clinical Trials Network. Journal of Substance Abuse Treatment. 38: S61-9. PMID 20307797 DOI: 10.1016/j.jsat.2009.12.010 |
0.321 |
|
| 2009 |
Chopra MP, Landes RD, Gatchalian KM, Jackson LC, Buchhalter AR, Stitzer ML, Marsch LA, Bickel WK. Buprenorphine medication versus voucher contingencies in promoting abstinence from opioids and cocaine. Experimental and Clinical Psychopharmacology. 17: 226-36. PMID 19653788 DOI: 10.1037/A0016597 |
0.311 |
|
| 2008 |
Rogers RE, Higgins ST, Silverman K, Thomas CS, Badger GJ, Bigelow G, Stitzer M. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 22: 544-50. PMID 19071979 DOI: 10.1037/0893-164X.22.4.544 |
0.705 |
|
| 2008 |
Cropsey K, Eldridge G, Weaver M, Villalobos G, Stitzer M, Best A. Smoking cessation intervention for female prisoners: addressing an urgent public health need. American Journal of Public Health. 98: 1894-901. PMID 18703440 DOI: 10.2105/Ajph.2007.128207 |
0.308 |
|
| 2008 |
Stitzer ML, Vandrey R. Contingency management: utility in the treatment of drug abuse disorders. Clinical Pharmacology and Therapeutics. 83: 644-7. PMID 18305456 DOI: 10.1038/sj.clpt.6100508 |
0.721 |
|
| 2007 |
Svikis DS, Silverman K, Haug NA, Stitzer M, Keyser-Marcus L. Behavioral strategies to improve treatment participation and retention by pregnant drug-dependent women. Substance Use & Misuse. 42: 1527-35. PMID 17918023 DOI: 10.1080/10826080701212121 |
0.563 |
|
| 2007 |
Stitzer ML, Peirce J, Petry NM, Kirby K, Roll J, Krasnansky J, Cohen A, Blaine J, Vandrey R, Kolodner K, Li R. Abstinence-based incentives in methadone maintenance: interaction with intake stimulant test results. Experimental and Clinical Psychopharmacology. 15: 344-50. PMID 17696681 DOI: 10.1037/1064-1297.15.4.344 |
0.707 |
|
| 2007 |
Vandrey R, Bigelow GE, Stitzer ML. Contingency management in cocaine abusers: a dose-effect comparison of goods-based versus cash-based incentives. Experimental and Clinical Psychopharmacology. 15: 338-43. PMID 17696680 DOI: 10.1037/1064-1297.15.4.338 |
0.761 |
|
| 2007 |
Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction (Abingdon, England). 102: 324-34. PMID 17222288 DOI: 10.1111/j.1360-0443.2006.01670.x |
0.521 |
|
| 2006 |
Stitzer M, Petry N. Contingency management for treatment of substance abuse. Annual Review of Clinical Psychology. 2: 411-34. PMID 17716077 DOI: 10.1146/Annurev.Clinpsy.2.022305.095219 |
0.378 |
|
| 2006 |
Juliano LM, Donny EC, Houtsmuller EJ, Stitzer ML. Experimental evidence for a causal relationship between smoking lapse and relapse. Journal of Abnormal Psychology. 115: 166-73. PMID 16492107 DOI: 10.1037/0021-843X.115.1.166 |
0.521 |
|
| 2006 |
Perkins KA, Stitzer M, Lerman C. Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology. 184: 628-36. PMID 16163529 DOI: 10.1007/S00213-005-0105-5 |
0.307 |
|
| 2005 |
Petry NM, Peirce JM, Stitzer ML, Blaine J, Roll JM, Cohen A, Obert J, Killeen T, Saladin ME, Cowell M, Kirby KC, Sterling R, Royer-Malvestuto C, Hamilton J, Booth RE, et al. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study. Archives of General Psychiatry. 62: 1148-56. PMID 16203960 DOI: 10.1001/Archpsyc.62.10.1148 |
0.311 |
|
| 2005 |
Donny EC, Brasser SM, Bigelow GE, Stitzer ML, Walsh SL. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. Addiction (Abingdon, England). 100: 1496-509. PMID 16185211 DOI: 10.1111/J.1360-0443.2005.01232.X |
0.687 |
|
| 2005 |
Correia CJ, Sigmon SC, Silverman K, Bigelow G, Stitzer ML. A comparison of voucher-delivery schedules for the initiation of cocaine abstinence. Experimental and Clinical Psychopharmacology. 13: 253-8. PMID 16173889 DOI: 10.1037/1064-1297.13.3.253 |
0.654 |
|
| 2005 |
Jones HE, Wong CJ, Tuten M, Stitzer ML. Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug and Alcohol Dependence. 79: 119-28. PMID 16002021 DOI: 10.1016/j.drugalcdep.2005.01.006 |
0.302 |
|
| 2005 |
Mintzer MZ, Copersino ML, Stitzer ML. Opioid abuse and cognitive performance. Drug and Alcohol Dependence. 78: 225-30. PMID 15845327 DOI: 10.1016/J.Drugalcdep.2004.10.008 |
0.65 |
|
| 2005 |
Lofwall MR, Stitzer ML, Bigelow GE, Strain EC. Comparative safety and side effect profiles of buprenorphine and methadone in the outpatient treatment of opioid dependence Addictive Disorders and Their Treatment. 4: 49-64. DOI: 10.1097/01.adt.0000145126.17405.6a |
0.493 |
|
| 2004 |
Katz EC, Chutuape MA, Jones H, Jasinski D, Fingerhood M, Stitzer M. Abstinence incentive effects in a short-term outpatient detoxification program. Experimental and Clinical Psychopharmacology. 12: 262-8. PMID 15571443 DOI: 10.1037/1064-1297.12.4.262 |
0.437 |
|
| 2004 |
Copersino ML, Serper MR, Vadhan N, Goldberg BR, Richarme D, Chou JC, Stitzer M, Cancro R. Cocaine craving and attentional bias in cocaine-dependent schizophrenic patients. Psychiatry Research. 128: 209-18. PMID 15541777 DOI: 10.1016/J.Psychres.2004.07.006 |
0.359 |
|
| 2004 |
Silverman K, Robles E, Mudric T, Bigelow GE, Stitzer ML. A randomized trial of long-term reinforcement of cocaine abstinence in methadone-maintained patients who inject drugs. Journal of Consulting and Clinical Psychology. 72: 839-54. PMID 15482042 DOI: 10.1037/0022-006X.72.5.839 |
0.668 |
|
| 2004 |
Cumberbatch Z, Copersino M, Stitzer M, Jones H. Comparative drug use and psychosocial profiles of opioid dependents applying for medication versus medication-free treatment. The American Journal of Drug and Alcohol Abuse. 30: 237-49. PMID 15230074 DOI: 10.1081/Ada-120037376 |
0.3 |
|
| 2003 |
Correia CJ, Dallery J, Katz EC, Silverman K, Bigelow G, Stitzer ML. Single- versus dual-drug target: effects in a brief abstinence incentive procedure. Experimental and Clinical Psychopharmacology. 11: 302-8. PMID 14599264 DOI: 10.1037/1064-1297.11.4.302 |
0.658 |
|
| 2002 |
Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: three-year abstinence outcomes. Experimental and Clinical Psychopharmacology. 10: 228-40. PMID 12233983 DOI: 10.1037//1064-1297.10.3.228 |
0.679 |
|
| 2002 |
Mintzer MZ, Stitzer ML. Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence. 67: 41-51. PMID 12062778 DOI: 10.1016/S0376-8716(02)00013-3 |
0.633 |
|
| 2002 |
Donny EC, Walsh SL, Bigelow GE, Eissenberg T, Stitzer ML. High-dose methadone produces superior opioid blockade and comparable withdrawal suppression to lower doses in opioid-dependent humans. Psychopharmacology. 161: 202-12. PMID 11981600 DOI: 10.1007/S00213-002-1027-0 |
0.685 |
|
| 2002 |
Katz EC, Robles-Sotelo E, Correia CJ, Silverman K, Stitzer ML, Bigelow G. The brief abstinence test: effects of continued incentive availability on cocaine abstinence. Experimental and Clinical Psychopharmacology. 10: 10-7. PMID 11866247 DOI: 10.1037/1064-1297.10.1.10 |
0.649 |
|
| 2002 |
Robles E, Stitzer ML, Strain EC, Bigelow GE, Silverman K. Voucher-based reinforcement of opiate abstinence during methadone detoxification. Drug and Alcohol Dependence. 65: 179-89. PMID 11772479 DOI: 10.1016/S0376-8716(01)00160-0 |
0.684 |
|
| 2002 |
Silverman K, Svikis D, Wong CJ, Hampton J, Stitzer ML, Bigelow GE. A reinforcement-based Therapeutic Workplace for the treatment of drug abuse: Three-year abstinence outcomes. Experimental and Clinical Psychopharmacology. 10: 228-240. DOI: 10.1037/1064-1297.10.3.228 |
0.656 |
|
| 2001 |
Dallery J, Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Experimental and Clinical Psychopharmacology. 9: 317-25. PMID 11534542 DOI: 10.1037/1064-1297.9.3.317 |
0.683 |
|
| 2001 |
Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Experimental and Clinical Psychopharmacology. 9: 14-23. PMID 11519628 DOI: 10.1037/1064-1297.9.1.14 |
0.686 |
|
| 2001 |
Becker AB, Strain EC, Bigelow GE, Stitzer ML, Johnson RE. Gradual dose taper following chronic buprenorphine. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 10: 111-21. PMID 11444154 DOI: 10.1080/105504901750227778 |
0.572 |
|
| 2001 |
Chutuape MA, Jasinski DR, Fingerhood MI, Stitzer ML. One-, three-, and six-month outcomes after brief inpatient opioid detoxification. The American Journal of Drug and Alcohol Abuse. 27: 19-44. PMID 11373035 DOI: 10.1081/ADA-100103117 |
0.332 |
|
| 2001 |
Katz EC, Gruber K, Chutuape MA, Stitzer ML. Reinforcement-based outpatient treatment for opiate and cocaine abusers. Journal of Substance Abuse Treatment. 20: 93-8. PMID 11239734 DOI: 10.1016/S0740-5472(00)00145-8 |
0.328 |
|
| 2001 |
Chutuape MA, Silverman K, Stitzer ML. Effects of urine testing frequency on outcome in a methadone take-home contingency program. Drug and Alcohol Dependence. 62: 69-76. PMID 11173169 DOI: 10.1016/S0376-8716(00)00160-5 |
0.59 |
|
| 2001 |
Jones HE, Haug N, Silverman K, Stitzer M, Svikis D. The effectiveness of incentives in enhancing treatment attendance and drug abstinence in methadone-maintained pregnant women. Drug and Alcohol Dependence. 61: 297-306. PMID 11164694 DOI: 10.1016/S0376-8716(00)00152-6 |
0.625 |
|
| 2001 |
Silverman K, Svikis D, Robles E, Stitzer ML, Bigelow GE. Toward application of the Therapeutic Workplace: Reply to Higgins (2001), Marlatt (2001), McLellan (2001), and Petry (2001) Experimental and Clinical Psychopharmacology. 9: 35-39. |
0.571 |
|
| 2000 |
Johnson RE, Chutuape MA, Strain EC, Walsh SL, Stitzer ML, Bigelow GE. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. The New England Journal of Medicine. 343: 1290-7. PMID 11058673 DOI: 10.1056/NEJM200011023431802 |
0.537 |
|
| 2000 |
Robles E, Silverman K, Preston KL, Cone EJ, Katz E, Bigelow GE, Stitzer ML. The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug and Alcohol Dependence. 58: 205-12. PMID 10669073 DOI: 10.1016/S0376-8716(99)00090-3 |
0.659 |
|
| 2000 |
Gruber K, Chutuape MA, Stitzer ML. Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation. Drug and Alcohol Dependence. 57: 211-23. PMID 10661672 DOI: 10.1016/S0376-8716(99)00054-X |
0.315 |
|
| 1999 |
Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology. 146: 128-38. PMID 10525747 DOI: 10.1007/S002130051098 |
0.653 |
|
| 1999 |
Eissenberg T, Stitzer ML, Bigelow GE, Buchhalter AR, Walsh SL. Relative potency of levo-alpha-acetylmethadol and methadone in humans under acute dosing conditions. The Journal of Pharmacology and Experimental Therapeutics. 289: 936-45. PMID 10215673 |
0.528 |
|
| 1999 |
Chutuape MA, Silverman K, Stitzer M. Contingent reinforcement sustains post-detoxification abstinence from multiple drugs: a preliminary study with methadone patients. Drug and Alcohol Dependence. 54: 69-81. PMID 10101619 DOI: 10.1016/S0376-8716(98)00144-6 |
0.615 |
|
| 1999 |
Strain EC, Bigelow GE, Liebson IA, Stitzer ML. Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. Jama. 281: 1000-5. PMID 10086434 DOI: 10.1001/jama.281.11.1000 |
0.565 |
|
| 1999 |
Chutuape MA, Silverman K, Stitzer ML. Use of methadone take-home contingencies with persistent opiate and cocaine abusers. Journal of Substance Abuse Treatment. 16: 23-30. PMID 9888118 DOI: 10.1016/S0740-5472(97)00318-8 |
0.595 |
|
| 1998 |
Jones HE, Strain EC, Bigelow GE, Walsh SL, Stitzer ML, Eissenberg T, Johnson RE. Induction with levomethadyl acetate: safety and efficacy. Archives of General Psychiatry. 55: 729-36. PMID 9707384 DOI: 10.1001/Archpsyc.55.8.729 |
0.544 |
|
| 1998 |
Houtsmuller EJ, Walsh SL, Schuh KJ, Johnson RE, Stitzer ML, Bigelow GE. Dose-response analysis of opioid cross-tolerance and withdrawal suppression during LAAM maintenance. The Journal of Pharmacology and Experimental Therapeutics. 285: 387-96. PMID 9580575 |
0.533 |
|
| 1998 |
Chutuape MA, Silverman K, Stitzer ML. Survey assessment of methadone treatment services as reinforcers. The American Journal of Drug and Alcohol Abuse. 24: 1-16. PMID 9513626 DOI: 10.3109/00952999809001695 |
0.528 |
|
| 1998 |
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Useful Predictors of Outcome in Methadone-Treated Patients Journal of Maintenance in the Addictions. 1: 15-28. DOI: 10.1300/J126V01N03_05 |
0.454 |
|
| 1997 |
Eissenberg T, Bigelow GE, Strain EC, Walsh SL, Brooner RK, Stitzer ML, Johnson RE. Dose-related efficacy of levomethadyl acetate for treatment of opioid dependence. A randomized clinical trial. Jama. 277: 1945-51. PMID 9200635 DOI: 10.1001/Jama.1997.03540480045037 |
0.547 |
|
| 1997 |
Eissenberg T, Johnson RE, Bigelow GE, Walsh SL, Liebson IA, Strain EC, Stitzer ML. Controlled opioid withdrawal evaluation during 72 h dose omission in buprenorphine-maintained patients. Drug and Alcohol Dependence. 45: 81-91. PMID 9179510 DOI: 10.1016/S0376-8716(97)01347-1 |
0.532 |
|
| 1997 |
Clemmey P, Brooner R, Chutuape MA, Kidorf M, Stitzer M. Smoking habits and attitudes in a methadone maintenance treatment population. Drug and Alcohol Dependence. 44: 123-32. PMID 9088784 DOI: 10.1016/S0376-8716(96)01331-2 |
0.36 |
|
| 1996 |
Silverman K, Chutuape MA, Bigelow GE, Stitzer ML. Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program. Drug and Alcohol Dependence. 41: 197-207. PMID 8842632 DOI: 10.1016/0376-8716(96)01252-5 |
0.625 |
|
| 1996 |
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology. 16: 58-67. PMID 8834420 |
0.58 |
|
| 1996 |
Schuh KJ, Walsh SL, Bigelow GE, Preston KL, Stitzer ML. Buprenorphine, morphine and naloxone effects during ascending morphine maintenance in humans. The Journal of Pharmacology and Experimental Therapeutics. 278: 836-46. PMID 8768738 |
0.51 |
|
| 1996 |
Eissenberg T, Greenwald MK, Johnson RE, Liebson IA, Bigelow GE, Stitzer ML. Buprenorphine's physical dependence potential: antagonist-precipitated withdrawal in humans. The Journal of Pharmacology and Experimental Therapeutics. 276: 449-59. PMID 8632309 |
0.516 |
|
| 1996 |
Johnson R, Eissenberg T, Bigelow G, Walsh S, Liebson I, Strain E, Stitzer M. A Pilot Study of Less-Than-Daily Dosing with Buprenorphine (B) Clinical Pharmacology & Therapeutics. 59: 210-210. DOI: 10.1038/Sj.Clpt.1996.341 |
0.46 |
|
| 1995 |
Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. Buprenorphine treatment of opioid dependence: clinical trial of daily versus alternate-day dosing. Drug and Alcohol Dependence. 40: 27-35. PMID 8746921 DOI: 10.1016/0376-8716(95)01189-7 |
0.566 |
|
| 1995 |
Johnson RE, Eissenberg T, Stitzer ML, Strain EC, Liebson IA, Bigelow GE. A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug and Alcohol Dependence. 40: 17-25. PMID 8746920 DOI: 10.1016/0376-8716(95)01186-2 |
0.564 |
|
| 1995 |
Silverman K, Chutuape MA, Svikis DS, Bigelow GE, Stitzer ML. Incongruity between occupational interests and academic skills in drug abusing women. Drug and Alcohol Dependence. 40: 115-23. PMID 8745133 DOI: 10.1016/0376-8716(95)01196-X |
0.62 |
|
| 1995 |
Walsh SL, June HL, Schuh KJ, Preston KL, Bigelow GE, Stitzer ML. Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology. 119: 268-76. PMID 7675960 DOI: 10.1007/Bf02246290 |
0.541 |
|
| 1995 |
Walsh SL, Preston KL, Bigelow GE, Stitzer ML. Acute administration of buprenorphine in humans: partial agonist and blockade effects. The Journal of Pharmacology and Experimental Therapeutics. 274: 361-72. PMID 7542336 |
0.533 |
|
| 1994 |
Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clinical Pharmacology and Therapeutics. 55: 569-80. PMID 8181201 DOI: 10.1097/00132586-199502000-00012 |
0.529 |
|
| 1994 |
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Comparison of buprenorphine and methadone in the treatment of opioid dependence. The American Journal of Psychiatry. 151: 1025-30. PMID 8010359 |
0.577 |
|
| 1994 |
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Outcome after methadone treatment: influence of prior treatment factors and current treatment status. Drug and Alcohol Dependence. 35: 223-30. PMID 7956752 DOI: 10.1016/0376-8716(94)90078-7 |
0.542 |
|
| 1994 |
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology. 116: 401-6. PMID 7701040 DOI: 10.1007/BF02247469 |
0.581 |
|
| 1994 |
Strain EC, Preston KL, Stitzer ML, Liebson IA, Bigelow GE. The effects of cocaine in buprenorphine-maintained outpatient volunteers. Results from clinical experience and laboratory challenges American Journal On Addictions. 3: 129-143. DOI: 10.3109/10550499409117246 |
0.527 |
|
| 1994 |
Strain EC, Preston KL, Stitzer ML, Liebson IA, Bigelow GE. The Effects of Cocaine in Buprenorphine-Maintained Outpatient Volunteers The American Journal On Addictions. 3: 129-143. DOI: 10.1111/J.1521-0391.1994.Tb00380.X |
0.525 |
|
| 1993 |
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Dose-response effects of methadone in the treatment of opioid dependence. Annals of Internal Medicine. 119: 23-7. PMID 8498759 |
0.581 |
|
| 1993 |
Stitzer ML, Iguchi MY, Kidorf M, Bigelow GE. Contingency management in methadone treatment: the case for positive incentives. Nida Research Monograph. 137: 19-36. PMID 8289921 |
0.452 |
|
| 1993 |
Strain EC, Stitzer ML, Liebson IA, Bigelow GE. Methadone dose and treatment outcome. Drug and Alcohol Dependence. 33: 105-17. PMID 8261875 DOI: 10.1016/0376-8716(93)90052-R |
0.579 |
|
| 1992 |
Stitzer ML, Iguchi MY, Felch LJ. Contingent take-home incentive: effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology. 60: 927-34. PMID 1460154 DOI: 10.1037//0022-006x.60.6.927 |
0.308 |
|
| 1991 |
Strain EC, Stitzer ML, Bigelow GE. Early treatment time course of depressive symptoms in opiate addicts. The Journal of Nervous and Mental Disease. 179: 215-21. PMID 2007892 DOI: 10.1097/00005053-199104000-00007 |
0.464 |
|
| 1991 |
Stitzer ML, Wright C, Bigelow GE, June HL, Felch LJ. Time course of naloxone-precipitated withdrawal after acute methadone exposure in humans. Drug and Alcohol Dependence. 29: 39-46. PMID 1665778 DOI: 10.1016/0376-8716(91)90020-Y |
0.489 |
|
| 1991 |
Wright C, Bigelow GE, Stitzer ML, Liebson IA. Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone. Drug and Alcohol Dependence. 27: 139-48. PMID 1647293 DOI: 10.1016/0376-8716(91)90033-U |
0.511 |
|
| 1990 |
Heishman SJ, Stitzer ML, Bigelow GE, Liebson IA. Acute opioid physical dependence in humans: effect of naloxone at 6 and 24 hours postmorphine. Pharmacology, Biochemistry, and Behavior. 36: 393-9. PMID 2356213 DOI: 10.1016/0091-3057(90)90421-D |
0.502 |
|
| 1989 |
Rand CS, Stitzer ML, Bigelow GE, Mead AM. The effects of contingent payment and frequent workplace monitoring on smoking abstinence. Addictive Behaviors. 14: 121-8. PMID 2728951 DOI: 10.1016/0306-4603(89)90041-5 |
0.509 |
|
| 1988 |
Bickel WK, Stitzer ML, Bigelow GE, Liebson IA, Jasinski DR, Johnson RE. A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clinical Pharmacology and Therapeutics. 43: 72-8. PMID 3275523 DOI: 10.1038/clpt.1988.13 |
0.589 |
|
| 1988 |
Iguchi MY, Stitzer ML, Bigelow GE, Liebson IA. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug and Alcohol Dependence. 22: 1-7. PMID 2906863 DOI: 10.1016/0376-8716(88)90030-0 |
0.575 |
|
| 1988 |
Heishman SJ, Stitzer ML, Bigelow GE. Alcohol and marijuana: comparative dose effect profiles in humans. Pharmacology, Biochemistry, and Behavior. 31: 649-55. PMID 2855116 DOI: 10.1016/0091-3057(88)90244-4 |
0.488 |
|
| 1986 |
Stitzer ML, Bickel WK, Bigelow GE, Liebson IA. Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug and Alcohol Dependence. 18: 341-8. PMID 3816530 DOI: 10.1016/0376-8716(86)90097-9 |
0.569 |
|
| 1986 |
Higgins ST, Stitzer ML, Bigelow GE, Liebson IA. Contingent methadone delivery: effects on illicit-opiate use. Drug and Alcohol Dependence. 17: 311-22. PMID 3757767 DOI: 10.1016/0376-8716(86)90080-3 |
0.551 |
|
| 1986 |
Stitzer ML, Rand CS, Bigelow GE, Mead AM. Contingent payment procedures for smoking reduction and cessation. Journal of Applied Behavior Analysis. 19: 197-202. PMID 3733589 DOI: 10.1901/jaba.1986.19-197 |
0.498 |
|
| 1985 |
Stitzer ML, Bigelow GE. Contingent reinforcement for reduced breath carbon monoxide levels: target-specific effects on cigarette smoking. Addictive Behaviors. 10: 345-9. PMID 4091067 DOI: 10.1016/0306-4603(85)90030-9 |
0.487 |
|
| 1985 |
Burling TA, Stitzer ML, Bigelow GE, Mead AM. Smoking topography and carbon monoxide levels in smokers. Addictive Behaviors. 10: 319-23. PMID 4083109 DOI: 10.1016/0306-4603(85)90014-0 |
0.483 |
|
| 1985 |
Higgins ST, Stitzer ML, McCaul ME, Bigelow GE, Liebson IA. Pupillary response to methadone challenge in heroin users. Clinical Pharmacology and Therapeutics. 37: 460-3. PMID 3979006 DOI: 10.1038/clpt.1985.71 |
0.539 |
|
| 1985 |
Stitzer ML, Bigelow GE, McCaul ME. Behavior therapy in drug abuse treatment: review and evaluation. Nida Research Monograph. 58: 31-50. PMID 3929125 |
0.312 |
|
| 1984 |
Stitzer ML, Bigelow GE, Liebson IA. Single-day methadone dose alteration: detectability and symptoms. Clinical Pharmacology and Therapeutics. 36: 244-50. PMID 6744782 DOI: 10.1038/clpt.1984.170 |
0.488 |
|
| 1984 |
McCaul ME, Stitzer ML, Bigelow GE, Liebson IA. Contingency management interventions: effects on treatment outcome during methadone detoxification. Journal of Applied Behavior Analysis. 17: 35-43. PMID 6725168 DOI: 10.1901/jaba.1984.17-35 |
0.564 |
|
| 1984 |
Stitzer ML, Bigelow GE. Contingent reinforcement for carbon monoxide reduction: within-subject effects of pay amount. Journal of Applied Behavior Analysis. 17: 477-83. PMID 6526768 DOI: 10.1901/jaba.1984.17-477 |
0.508 |
|
| 1984 |
Stitzer ML, McCaul ME, Bigelow GE, Liebson IA. Chronic opiate use during methadone detoxification: effects of a dose increase treatment. Drug and Alcohol Dependence. 14: 37-44. PMID 6489151 DOI: 10.1016/0376-8716(84)90017-6 |
0.562 |
|
| 1984 |
Stitzer ML, Bigelow GE. Contingent methadone take-home privileges: effects on compliance with fee payment schedules. Drug and Alcohol Dependence. 13: 395-9. PMID 6479018 DOI: 10.1016/0376-8716(84)90007-3 |
0.482 |
|
| 1984 |
Preston KL, Griffiths RR, Stitzer ML, Bigelow GE, Liebson IA. Diazepam and methadone interactions in methadone maintenance. Clinical Pharmacology and Therapeutics. 36: 534-41. PMID 6478738 DOI: 10.1038/Clpt.1984.215 |
0.551 |
|
| 1983 |
Stitzer ML, McCaul ME, Bigelow GE, Liebson IA. Oral methadone self-administration: effects of dose and alternative reinforcers. Clinical Pharmacology and Therapeutics. 34: 29-35. PMID 6861436 DOI: 10.1038/clpt.1983.124 |
0.545 |
|
| 1983 |
Stitzer ML, McCaul ME, Bigelow GE, Liebson I. Treatment outcome in methadone detoxification: relationship to initial levels of illicit opiate use. Drug and Alcohol Dependence. 12: 259-67. PMID 6653395 DOI: 10.1016/0376-8716(83)90068-6 |
0.544 |
|
| 1983 |
Stitzer ML, Bigelow GE. Contingent payment for carbon monoxide reduction: Effects of pay amount Behavior Therapy. 14: 647-656. DOI: 10.1016/S0005-7894(83)80057-4 |
0.396 |
|
| 1982 |
Stitzer ML, Bigelow GE. Contingent reinforcement for reduced carbon monoxide levels in cigarette smokers. Addictive Behaviors. 7: 403-12. PMID 7183194 DOI: 10.1016/0306-4603(82)90010-7 |
0.502 |
|
| 1982 |
Burling TA, Stitzer ML, Bigelow GE, Russ NW. Techniques used by smokers during contingency motivated smoking reduction. Addictive Behaviors. 7: 397-401. PMID 7183193 DOI: 10.1016/0306-4603(82)90009-0 |
0.493 |
|
| 1982 |
Baile WF, Bigelow GE, Gottlieb SH, Stitzer ML, Sacktor JD. Rapid resumption of cigarette smoking following myocardial infarction: inverse relation to MI severity. Addictive Behaviors. 7: 373-80. PMID 7183190 DOI: 10.1016/0306-4603(82)90006-5 |
0.481 |
|
| 1982 |
McCaul ME, Bigelow GE, Stitzer ML, Liebson I. Short-term effects of oral methadone in methadone maintenance subjects. Clinical Pharmacology and Therapeutics. 31: 753-61. PMID 7075123 DOI: 10.1038/clpt.1982.106 |
0.514 |
|
| 1982 |
Stitzer ML, Bigelow GE, Liebson IA, Hawthorne JW. Contingent reinforcement for benzodiazepine-free urines: evaluation of a drug abuse treatment intervention. Journal of Applied Behavior Analysis. 15: 493-503. PMID 6130059 DOI: 10.1901/jaba.1982.15-493 |
0.554 |
|
| 1981 |
Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthorne JW. Diazepam use among methadone maintenance patients: patterns and dosages. Drug and Alcohol Dependence. 8: 189-99. PMID 7327083 DOI: 10.1016/0376-8716(81)90061-2 |
0.324 |
|
| 1981 |
Bigelow GE, Stitzer ML, Griffiths RR, Liebson IA. Contingency management approaches to drug self-administration and drug abuse: efficacy and limitations. Addictive Behaviors. 6: 241-52. PMID 7293847 DOI: 10.1016/0306-4603(81)90022-8 |
0.483 |
|
| 1981 |
Stitzer ML, Griffiths RR, Bigelow GE, Liebson I. Human social conversation: effects of ethanol, secobarbital and chlorpromazine. Pharmacology, Biochemistry, and Behavior. 14: 353-60. PMID 7232461 DOI: 10.1016/0091-3057(81)90402-0 |
0.488 |
|
| 1980 |
Bigelow G, Stitzer M, Lawrence C, Krasnegor N, D'Lugoff B, Hawthorne J. Narcotics addiction treatment: behavioral methods concurrent with methadone maintenance. The International Journal of the Addictions. 15: 427-37. PMID 7380601 DOI: 10.3109/10826088009040028 |
0.584 |
|
| 1980 |
Stitzer ML, Bigelow GE, Liebson I. Reducing drug use among methadone maintenance clients: contingent reinforcement for morphine-free urines. Addictive Behaviors. 5: 333-40. PMID 7211531 DOI: 10.1016/0306-4603(80)90007-6 |
0.511 |
|
| 1979 |
Stitzer ML, Bigelow GE, Liebson I. Reducing benzodiazepine self-administration with contingent reinforcement. Addictive Behaviors. 4: 245-52. PMID 495248 DOI: 10.1016/0306-4603(79)90034-0 |
0.446 |
|
| 1979 |
Stitzer M, Bigelow G, Liebson I. Supplementary methadone self administration among methadone maintenance clients. Addictive Behaviors. 4: 61-6. PMID 420047 DOI: 10.1016/0306-4603(79)90022-4 |
0.464 |
|
| 1978 |
Griffiths RR, Stitzer M, Corker K, Bigelow G, Liebson I. Drug-produced changes in human social behavior: facilitation by d-amphetamine. Pharmacology, Biochemistry, and Behavior. 7: 365-72. PMID 928495 DOI: 10.1016/0091-3057(77)90233-7 |
0.469 |
|
| 1978 |
Stitzer M, Bigelow G. Contingency management in a methadone maintenance program: availability of reinforcers. The International Journal of the Addictions. 13: 737-46. PMID 721332 DOI: 10.3109/10826087809039299 |
0.54 |
|
| 1977 |
Stitzer M, Bigelow G, Lawrence C, Cohen J, D'Lugoff B, Hawthorne J. Medication take-home as a reinforcer in a methadone maintenance program. Addictive Behaviors. 2: 9-14. PMID 848377 DOI: 10.1016/0306-4603(77)90003-X |
0.56 |
|
| 1975 |
Winger G, Stitzer ML, Woods JH. Barbiturate-reinforced responding in rhesus monkeys: comparisons of drugs with different durations of action. The Journal of Pharmacology and Experimental Therapeutics. 195: 505-14. PMID 811787 |
0.464 |
|
| 1968 |
Stitzer M, Isaacson RL. Scopolamine effects on activity and paper shredding in the gerbil Meriones unguiculatus Psychonomic Science. 12: 175-176. DOI: 10.3758/BF03331256 |
0.429 |
|
| Show low-probability matches. |